BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25275525)

  • 1. Oncocytoma-like renal tumor with transformation toward high-grade oncocytic carcinoma: a unique case with morphologic, immunohistochemical, and genomic characterization.
    Sirintrapun SJ; Geisinger KR; Cimic A; Snow A; Hagenkord J; Monzon F; Legendre BL; Ghazalpour A; Bender RP; Gatalica Z
    Medicine (Baltimore); 2014 Oct; 93(15):e81. PubMed ID: 25275525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases.
    Petersson F; Gatalica Z; Grossmann P; Perez Montiel MD; Alvarado Cabrero I; Bulimbasic S; Swatek A; Straka L; Tichy T; Hora M; Kuroda N; Legendre B; Michal M; Hes O
    Virchows Arch; 2010 Apr; 456(4):355-65. PubMed ID: 20300772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "High-grade oncocytic renal tumor": morphologic, immunohistochemical, and molecular genetic study of 14 cases.
    He H; Trpkov K; Martinek P; Isikci OT; Maggi-Galuzzi C; Alaghehbandan R; Gill AJ; Tretiakova M; Lopez JI; Williamson SR; Montiel DP; Sperga M; Comperat E; Brimo F; Yilmaz A; Pivovarcikova K; Michalova K; Slouka D; Prochazkova K; Hora M; Bonert M; Michal M; Hes O
    Virchows Arch; 2018 Dec; 473(6):725-738. PubMed ID: 30232607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.
    Liu YJ; Ussakli C; Antic T; Liu Y; Wu Y; True L; Tretiakova MS
    Hum Pathol; 2020 Oct; 104():18-29. PubMed ID: 32673684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
    Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M
    Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal oncocytosis: a morphologic study of fourteen cases.
    Tickoo SK; Reuter VE; Amin MB; Srigley JR; Epstein JI; Min KW; Rubin MA; Ro JY
    Am J Surg Pathol; 1999 Sep; 23(9):1094-101. PubMed ID: 10478670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of germline BHD mutation on histological concordance and clinical treatment of patients with bilateral renal masses and known unilateral oncocytoma.
    Boris RS; Benhammou J; Merino M; Pinto PA; Linehan WM; Bratslavsky G
    J Urol; 2011 Jun; 185(6):2050-5. PubMed ID: 21496834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of renal oncocytosis (multiple oncocytic lesions) with focus on clinical and pathobiological aspects.
    Kuroda N; Tanaka A; Ohe C; Mikami S; Nagashima Y; Sasaki T; Inoue K; Hes O; Michal M; Brunelli M; Martignoni G
    Histol Histopathol; 2012 Nov; 27(11):1407-12. PubMed ID: 23018240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
    Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
    Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists.
    Williamson SR; Gadde R; Trpkov K; Hirsch MS; Srigley JR; Reuter VE; Cheng L; Kunju LP; Barod R; Rogers CG; Delahunt B; Hes O; Eble JN; Zhou M; McKenney JK; Martignoni G; Fleming S; Grignon DJ; Moch H; Gupta NS
    Hum Pathol; 2017 May; 63():149-156. PubMed ID: 28315424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-Grade Oncocytic Tumor of Kidney (CK7-Positive, CD117-Negative): Incidence in a single institutional experience with clinicopathological and molecular characteristics.
    Kravtsov O; Gupta S; Cheville JC; Sukov WR; Rowsey R; Herrera-Hernandez LP; Lohse CM; Knudson R; Leibovich BC; Jimenez RE
    Hum Pathol; 2021 Aug; 114():9-18. PubMed ID: 33961838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warthin-like papillary renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 11 cases.
    Skenderi F; Ulamec M; Vanecek T; Martinek P; Alaghehbandan R; Foix MP; Babankova I; Montiel DP; Alvarado-Cabrero I; Svajdler M; Dubinský P; Cempirkova D; Pavlovsky M; Vranic S; Daum O; Ondic O; Pivovarcikova K; Michalova K; Hora M; Rotterova P; Stehlikova A; Dusek M; Michal M; Hes O
    Ann Diagn Pathol; 2017 Apr; 27():48-56. PubMed ID: 28325361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.
    Tan MH; Wong CF; Tan HL; Yang XJ; Ditlev J; Matsuda D; Khoo SK; Sugimura J; Fujioka T; Furge KA; Kort E; Giraud S; Ferlicot S; Vielh P; Amsellem-Ouazana D; Debré B; Flam T; Thiounn N; Zerbib M; Benoît G; Droupy S; Molinié V; Vieillefond A; Tan PH; Richard S; Teh BT
    BMC Cancer; 2010 May; 10():196. PubMed ID: 20462447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing oncologic outcomes in patients undergoing surgery for oncocytic neoplasms, conventional oncocytoma, and chromophobe renal cell carcinoma.
    Flack CK; Calaway AC; Miller BL; Picken MM; Gondim DD; Idrees MT; Abel EJ; Gupta GN; Boris RS
    Urol Oncol; 2019 Nov; 37(11):811.e17-811.e21. PubMed ID: 31451335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel intronic germline FLCN gene mutation in a patient with multiple ipsilateral renal neoplasms.
    Gatalica Z; Lilleberg SL; Vranic S; Eyzaguirre E; Orihuela E; Velagaleti G
    Hum Pathol; 2009 Dec; 40(12):1813-9. PubMed ID: 19733897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A collision tumor of papillary renal cell carcinoma and oncocytoma: case report and literature review.
    Goyal R; Parwani AV; Gellert L; Hameed O; Giannico GA
    Am J Clin Pathol; 2015 Nov; 144(5):811-6. PubMed ID: 26486747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concordance of MTOR Pathway Mutations and the Diagnosis of Renal Low-Grade Oncocytic Tumor (LOT).
    Siegmund SE; Al-Obaidy KI; Tsai HK; Idrees MT; Akgul M; Acosta AM; Hirsch MS
    Int J Surg Pathol; 2024 Apr; 32(2):316-330. PubMed ID: 37357748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid oncocytic/chromophobe renal cell tumor: An integrated genetic and epigenetic characterization of a case.
    Pires-Luis A; Montezuma D; Vieira J; Ramalho-Carvalho J; Santos C; Teixeira M; Jerónimo C; Henrique R
    Exp Mol Pathol; 2018 Dec; 105(3):352-356. PubMed ID: 30343009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma.
    Ruiz-Cordero R; Rao P; Li L; Qi Y; Atherton D; Peng B; Singh RR; Kim TB; Kawakami F; Routbort MJ; Alouch N; Chow CB; Tang X; Lu W; Brimo F; Matin SF; Wood CG; Tannir NM; Wistuba II; Chen K; Wang J; Medeiros LJ; Karam JA; Tamboli P; Sircar K
    Mod Pathol; 2019 Nov; 32(11):1698-1707. PubMed ID: 31231128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do we need an updated classification of oncocytic renal tumors? : Emergence of low-grade oncocytic tumor (LOT) and eosinophilic vacuolated tumor (EVT) as novel renal entities.
    Hes O; Trpkov K
    Mod Pathol; 2022 Sep; 35(9):1140-1150. PubMed ID: 35273336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.